E Gafney

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

Abraham Mittelman, M. Huberman, Carmelo Puccio et al. · Cancer · 1990 · 41 citations

Immunology, Pharmacotherapy, Malignant Melanoma +19

A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion

Abraham Mittelman, Carmelo Puccio, E Gafney et al. · Investigational New Drugs · 1992 · 40 citations

Inflammation, Thrombosis, Medicine +10

Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells

Mitchel S. Hoffman, Abraham Mittelman, Brad Dworkin et al. · Journal of Cancer Research and Clinical Oncology · 1989 · 20 citations · Full text

Inflammation, Severe Intrahepatic Cholestasis, Autoimmune Disease +14

Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2.

Abraham Mittelman, S. Savona, E Gafney et al. · PubMed · 1989 · 13 citations

Cell Therapy, Long-term Cultured Ril-2, Immunology +20